Recommendations for the future of translational radiobiology research: a Canadian perspective

被引:10
作者
Bristow, RG
机构
[1] Princess Margaret Hosp, Dept Radiat Oncol, Univ Hlth Network, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
关键词
radiobiology; translational oncology; training; curriculum; clinician-scientist;
D O I
10.1016/j.radonc.2004.02.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The use of molecular medicine is now merging into clinical practice with the advent of molecular targeting agents, molecular pathology and molecular imaging for both diagnosis and treatment response. Radiation oncologists must therefore gain expertise in utilizing this information to drive new treatment protocols. Recognizing the importance of this issue, the Canadian Association of Radiation Oncologists (CARO) charged a Task Force in Translational Radiobiology to: (1) critically assess training programs and research infrastructure in relation to current and future translational radiobiology requirements; and (2) make specific recommendations to accelerate the implementation of translational science into day-to-day practice. Selected Task Force recommendations included the principle that universities and departmental Chairs increase the opportunities for academic promotion, funding, and tenure track positions of radiobiologists and translational radiation oncologists. The dedication of 4 to 5 national centers as translational 'hubs', can serve as an interface between clinicians, clinical specimens and radiobiological sciences within the context of correlative clinical trials. The model of the clinician-scientist was encouraged as an important adjunct to good clinical care to be associated with strong enticement, training and mentoring programs and 75%-protected research time. Finally, an integrated model of radiobiological training programs and mutual continuing education between clinicians and basic scientists can be facilitated through a new national radiobiology meeting sponsored by CARO. These recommendations have been accepted by the national radiation oncology membership. Such a framework may serve useful for national programs wishing to develop rapid conduits from the lab to the clinic as a means of integrating molecular biology and the day-to-day practice of radiation oncology. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 13 条
[1]   Young Investigators Workshop-radiation research program, Radiation Oncology Sciences Program, National Cancer Institute, NIH, August 1-2 2000 [J].
CColeman, N. .
International Journal of Radiation Oncology Biology Physics, 2001, 49 (05) :1505-1516
[2]  
CUDDIHY A, 2004, IN PRESS CANC METAST
[3]   Waiting lists for radiation therapy: A case study [J].
D'Souza, DP ;
Martin, DK ;
Purdy, L ;
Bezjak, A ;
Singer, PA .
BMC HEALTH SERVICES RESEARCH, 2001, 1 (1)
[4]  
Dynlacht JR, 2002, RADIAT RES, V157, P599, DOI 10.1667/0033-7587(2002)157[0599:TACORT]2.0.CO
[5]  
2
[6]   Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer [J].
Fyles, A ;
Milosevic, M ;
Hedley, D ;
Pintilie, M ;
Levin, W ;
Manchul, L ;
Hill, RP .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :680-687
[7]   Radiation oncology in Canada 1895-1995 [J].
Hayter, CRR ;
Payne, D ;
Ege, GN .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (02) :487-496
[8]   Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents [J].
Ma, BBY ;
Bristow, RG ;
Kim, J ;
Siu, LL .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2760-2776
[9]   Changes in the use of radiotherapy in Ontario 1984-1995 [J].
Mackillop, WJ ;
Zhou, S ;
Groome, P ;
Dixon, P ;
Cummings, BJ ;
Hayter, C ;
Paszat, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (02) :355-362
[10]  
Pearcey RG, 2001, CAN MED ASSOC J, V165, P886